During the past decade, Baystate Infectious Diseases Clinical Research conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 8 clinical trials were completed, i.e. on average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Baystate Infectious Diseases Clinical Research" #1 sponsor was "Gilead Sciences" with 7 trials, followed by "ViiV Healthcare" with 2 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "University of Minnesota" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Baystate Infectious Diseases Clinical Research" #1 collaborator was "Pfizer" with 2 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator and "National Institutes of Health (NIH)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Baystate Infectious Diseases Clinical Research" are "HIV Infections" (5 trials), "HIV" (4 trials), "HIV-1" (2 trials), "HIV-1 Infection" (2 trials) and "Acquired Immunodeficiency Syndrome" (1 trials). Many other conditions were trialed in "Baystate Infectious Diseases Clinical Research" in a lesser frequency.

Most popular intervention types in "Baystate Infectious Diseases Clinical Research" are "Drug" (9 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "E/C/F/TAF" (3 trials), "ATV" (2 trials), "E/C/F/TDF" (2 trials), "EFV/FTC/TDF" (2 trials) and "FTC/RPV/TAF" (2 trials). Other intervention names were less common.

The vast majority of trials in "Baystate Infectious Diseases Clinical Research" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Baystate Infectious Diseases Clinical Research". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Baystate Infectious Diseases Clinical Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Baystate Infectious Diseases Clinical Research, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".